(70 days)
510/k) 973597
No
The document describes a standard soft contact lens made of a specific material and does not mention any AI or ML components or functionalities.
No.
The contact lenses are indicated for the correction of visual acuity, which means they are intended to improve vision rather than treat a disease or condition.
No.
Explanation: The device is a soft contact lens intended for the correction of visual acuity (a treatment), not for identifying or diagnosing a medical condition.
No
The device description clearly states it is a physical contact lens made from specific materials, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the correction of visual acuity in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. This is a therapeutic and corrective function, not a diagnostic one.
- Device Description: The description details the physical properties and composition of a contact lens, which is a medical device used for vision correction.
- Lack of Diagnostic Function: There is no mention of the device being used to diagnose a condition, analyze a sample from the human body, or provide information for diagnostic purposes.
- Performance Studies: The performance studies focus on the safety and effectiveness of the lens material and its compatibility with cleaning solutions, not on diagnostic accuracy or performance.
IVD devices are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. This contact lens does not perform any of these functions.
N/A
Intended Use / Indications for Use
The CONTAFLEX GM3 49 (acofilcon B) Spherical Soft Contact Lenses for daily wear are indicated for the correction of visual acuity in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by persons who exhibit refractive astigmatism of .75 diopters or less where the astigmatism does not interfere with visual acuity.
The lens may be disinfected using a chemical disinfecting system.
Evecare practitioners may prescribe the lenses for frequent/planned replacement wear, with cleaning, disinfection and scheduled replacement. When prescribed for frequent/planned replacement wear, the lens may be cleaned and disinfected using a chemical (not heat) lens care system.
Product codes (comma separated list FDA assigned to the subject device)
LPL
Device Description
The CONTAFLEX GM3 49% Spherical Soft Contact Lenses are fabricated from acofilcon B, which in the dry (unhydrated) state may be machined and polished. The hydrophilic nature of this material allows the lens to become soft and pliable when immersed in an aqueous solution.
The non-ionic lens material, (acofilcon B) is a terpolymer based on high purity Glycerol Methacrylate 2.3-Dihydroxypropyl Methacrylate (GMA), with N-vinyl-2-pyrrolidone (NVP), methyl methacrylate (MMA), and 2-hydroxyethyl methacrylate (2-HEMA) and cross-linked with Diallyl Maleate (DAM). It consists of 51% acofilcon B and 49% water by weight when immersed in normal saline solution buffered with sodium bicarbonate. The lens is available in clear and with a blue visibility-handling tint. Color additive 'Reactive Blue 4' 21 CFR part 73.2121. The acofilcon B name has been adopted by the United States Adopted Names Council (USAN).
In the hydrated state, the lens conforms to the curvature of the eye covering the cornea and extending slightly beyond the limbus forming a colorless, transparent optical surface. The (acofilcon B) soft hydrophilic contact lens has a spherical back surface. The hydrophilic properties of the lens require that it be maintained in a fully hydrated state in a solution compatible with the eye. If the lens dries out, it will become hard and appear somewhat warped however, it will return to its proper configuration when completely rehydrated in the proper storage solution.
The hydrophilic characteristics allow aqueous solutions to enter the lens and in its filly hydrated state the lens is approximately 49% water by weight. The physical properties of the lens are:
Refractive Index 1.52 (dry) 1.42 (hydrated)
Light Transmission greater than 96%
Water Content 49 %
Specific Gravity 1.142 (hydrated)
Oxygen Permeability 15.89 X 10-11 (cm2/sec) (ml O₂/ml x hPa @ 35°C), (revised Fatt method).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
eyes, cornea
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Eyecare practitioners
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
A series of preclinical testing were performed to demonstrate the safety and effectiveness of the CONTAFLEX GM3 49 Soft Contact Lens material. The results of all testing demonstrated that the safety and effectiveness of the CONTAFLEX GM3 49 Soft Contact Lens is equivalent to the currently marketed Benz-G3X contact lens material, as well as the CONTAFLEX GM3 58.
Toxicology:
In-Vitro Cvtotoxicity: ISO 10993-5 was conducted in accordance with standards on test article. The test article meets the requirements of the Agarose Overlay Method.
Systemic Toxicity: The lens material meets the requirements of the systemic injection test and is considered non-toxic.
Acute Ocular Irritation: Acute ocular irritation test was performed and produced no ocular irritation.
Shelf Life:
Shelf life requirements are satisfied via referencing rights granted to Contamac Ltd. for 510/k) 973597. The data presented supports substantial equivalence of this CONTAFLEX GM3 49 Soft Contact Lens material to the already marketed Benz-G3X.
Solution Compatibility:
Studies were conducted on blue tinted lens material. Lenses were run through 30 cycles of cleaning and conditioning to establish the compatibility of the lens material with the recommended care regimen. The parameters of the base curve, back vertex power, total diameter and overall lens physical appearance were recorded prior to and upon completion of 30 cycles. Initial and final data were compared. There were no significant changes to lens parameters after 30 complete cvcles.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
510/k) 973597
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 886.5925 Soft (hydrophilic) contact lens.
(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.
0
FEB 1 4 2003
510 (k) SUMMARY OF SAFETY AND EFFECTIVENESS
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92
The assigned 510(k) number is:
Applicant information:
| Date Prepared: | November 27, 2002 |
|---|---|
| Name: | CONTAMAC Ltd. |
| Address | Bearwalden Business Park |
| Saffron Walden | |
| Essex England CB11 4JX | |
| Contact Person: | Robert McGregor |
| Phone number: | 44-1799 542 000 |
| US Agent: | Medvice Consulting, Inc. |
| Martin Dalsing | |
| Phone number | (970) 243-5490 |
| Fax number | (970) 243-5501 |
Device Information:
| Device Classification: | Class II |
|---|---|
| Classification Number: | LPL |
| Classification Name: | Lenses, Soft Contact, Daily Wear |
| Trade Name: | CONTAFLEX GM3 49% (acofilcon B) Spherical Soft |
| Contact Lens for Daily Wear (clear and tinted, lathe-cut) |
1
Equivalent Devices:
The CONTAFILEX GM3 49% (acofilcon B) Spherical Soft Contact Lenses are substantially equivalent to the following predicate device
| Predicate devices: | "BENZ-G3X" manufactured/distributed by Benz Research and Development.
(hioxifilcon B)
510(k) number; K964528 |
|--------------------|--------------------------------------------------------------------------------------------------------------------|
| | "CONTAFLEX GM3 58%" manufactured by Contamac Ltd.
(acofilcon A)
510(k) number: K023349 |
Device Description:
The CONTAFLEX GM3 49% Spherical Soft Contact Lenses are fabricated from acofilcon B, which in the dry (unhydrated) state may be machined and polished. The hydrophilic nature of this material allows the lens to become soft and pliable when immersed in an aqueous solution.
The non-ionic lens material, (acofilcon B) is a terpolymer based on high purity Glycerol Methacrylate 2.3-Dihydroxypropyl Methacrylate (GMA), with N-vinyl-2-pyrrolidone (NVP), methyl methacrylate (MMA), and 2-hydroxyethyl methacrylate (2-HEMA) and cross-linked with Diallyl Maleate (DAM). It consists of 51% acofilcon B and 49% water by weight when immersed in normal saline solution buffered with sodium bicarbonate. The lens is available in clear and with a blue visibility-handling tint. Color additive 'Reactive Blue 4' 21 CFR part 73.2121. The acofilcon B name has been adopted by the United States Adopted Names Council (USAN).
In the hydrated state, the lens conforms to the curvature of the eye covering the cornea and extending slightly beyond the limbus forming a colorless, transparent optical surface. The (acofilcon B) soft hydrophilic contact lens has a spherical back surface. The hydrophilic properties of the lens require that it be maintained in a fully hydrated state in a solution compatible with the eye. If the lens dries out, it will become hard and appear somewhat warped however, it will return to its proper configuration when completely rehydrated in the proper storage solution.
The hydrophilic characteristics allow aqueous solutions to enter the lens and in its filly hydrated state the lens is approximately 49% water by weight. The physical properties of the lens are:
| Refractive Index | 1.52 (dry) 1.42 (hydrated) |
|---|---|
| Light Transmission | greater than 96% |
| Water Content | 49 % |
| Specific Gravity | 1.142 (hydrated) |
| Oxygen Permeability | 15.89 X 10-11 (cm2/sec) (ml O₂/ml x hPa @ 35°C), (revised Fatt method). |
2
Intended Use:
The CONTAFLEX GM3 49 (acofilcon B) Spherical Soft Contact Lenses for daily wear are indicated for the correction of visual acuity in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by persons who exhibit refractive astigmatism of .75 diopters or less where the astigmatism does not interfere with visual acuity.
The lens may be disinfected using a chemical disinfecting system.
Evecare practitioners may prescribe the lenses for frequent/planned replacement wear, with cleaning, disinfection and scheduled replacement. When prescribed for frequent/planned replacement wear, the lens may be cleaned and disinfected using a chemical (not heat) lens care system.
Description of Safety:
A series of preclinical testing were performed to demonstrate the safety and effectiveness of the CONTAFLEX GM3 49 Soft Contact Lens material. The results of all testing demonstrated that the safety and effectiveness of the CONTAFLEX GM3 49 Soft Contact Lens is equivalent to the currently marketed Benz-G3X contact lens material, as well as the CONTAFLEX GM3 58. A summary of these results from the preclinical studies is presented below.
Toxicology:
In-Vitro Cvtotoxicity: ISO 10993-5 was conducted in accordance with standards on test article. The test article meets the requirements of the Agarose Overlay Method.
Systemic Toxicity: The lens material meets the requirements of the systemic injection test and is considered non-toxic.
Acute Ocular Irritation: Acute ocular irritation test was performed and produced no ocular irritation.
Shelf Life
Shelf life requirements are satisfied via referencing rights granted to Contamac Ltd. for 510/k) 973597. The data presented supports substantial equivalence of this CONTAFLEX GM3 49 Soft Contact Lens material to the already marketed Benz-G3X.
Solution Compatibility
Studies were conducted on blue tinted lens material. Lenses were run through 30 cycles of cleaning and conditioning to establish the compatibility of the lens material with the recommended care regimen. The parameters of the base curve, back vertex power, total diameter and overall lens physical appearance were recorded prior to and upon completion of 30 cycles. Initial and final data were compared. There were no significant changes to lens parameters after 30 complete cvcles.
3
Substantial Equivalence:
The CONTAFLEX GM3 49 Soft Contact Lens is substantial equivalent and does not raise different questions of safety and effectiveness than the predicate devices identified previously. The difference between the two devices is the USAN name.
The following table depicts the pre-clinical characteristics of the CONTAFLEX GM3 49 material, as compared to the predicate device.
| | Pre-Clinical
equivalency / Device | CONTAFLEX GM3 49%
(acofilcon B) | BENZ-G3X
(hioxifilcon B) |
|-----|--------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1.) | Intended Use | Indicated for daily wear for the
correction of visual acuity in
aphakic and not aphakic persons
with non-diseased eyes with
myopia or hyperopia. | Indicated for daily wear for the
correction of visual acuity in
aphakic and not aphakic persons
with non-diseased eyes with
myopia or hyperopia. |
| 2.) | Functionality | After machining from the optical
blank, the contact lenses act as a
refractive medium that focus light
rays from near and distant objects
on the retina. | After machining from the optical
blank, the contact lenses act as a
refractive medium that focus light
rays from near and distant objects
on the retina. |
| 3.) | Indications | Daily wear, Soft (hydrophilic)
contact lens | Daily wear, Soft (hydrophilic)
contact lens |
| 4.) | Production Method | Lathe-cut | Lathe-cut |
| 5.) | FDA Group # | Group # 2 >50% Water, Nonionic
Polymers | Group # 2 >50% Water, Nonionic
Polymers |
| 6.) | USAN name | Acoficon B | Hioxifilcon B |
| 7.) | Water Content | 48.0% | 48.0% |
| 8.) | Oxygen Permeability | 15.89 X 10-11 (cm2/sec)
(ml O2/ml x mm Hg @ 35 degrees
C), (revised Fatt method). | 16.40 X 10-11 (cm2/sec)
(ml O2/ml x mm Hg @ 35 degrees
C), (revised Fatt method). |
| 9.) | Specific Gravity | 1.142 | 1.137 |
Substantial Equivalence table
4
Image /page/4/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's emblem, which is a stylized representation of an eagle or bird-like figure. The emblem is enclosed within a circular border, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged around the upper portion of the circle.
FEB 1 4 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Contamac, Ltd C/O Martin Dalsing Medvice Consulting, Inc. 623 Glacier Dr. Grand Junction, CO 81503
Re: K024045 Trade/Device Name: CONTAFLEX GM3 49% (acofilcon B) Soft Contact Lens for Daily Wear (clear and tinted, lathe-cut) Regulation Number: 21 CFR 886.5925 Regulation Name: Soft (hydrophilic) contact lens Regulatory Class: Class II Product Code: LPL Dated: November 27, 2002 Received: December 6, 2002
Dear Mr. Dalsing:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
5
Page 2 -- Mr. Martin Dalsing
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
A, Ralph Rosenthal
A. Ralph Rosenthal, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
INDICATIONS FOR USE STATEMENT
CONTAFLEX GM3 49% (acofilcon B) Spherical Soft Contact Lens for Daily Device Name: Wear (clear and tinted, lathe-cut)
INDICATIONS FOR USE:
The CONTAFLEX GM3 58 (acofilcon B) Spherical Soft Contact Lenses for daily wear are indicated for the correction of visual acuity in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by persons who exhibit refractive astigmatism of .75 diopters or less where the astigmatism does not interfere with visual acuity.
The lens may be disinfected using a chemical disinfecting system.
Eyecare practitioners may prescribe the lenses for frequent/planned replacement wear, with cleaning, disinfection and scheduled replacement. When prescribed for frequent/planned replacement wear, the lens may be cleaned and disinfected using a chemical (not heat) lens care system.
(PLEASE DO OT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of CDRH, Office of Device Evaluation (ODE) | |
|---|---|
| -------------------------------------------------------- | -- |
Prescription Use
(Per 21 CFR 801.109)
or
Over-The-Counter Use
(Optional Format 1-2-96)
Savota
(Division Sign Off) Division of Ophthalmic Ear, Nose and Throat Devises
510(k) Number K024045